ATPase Inhibitory Factor 1 Promotes Hepatocellular Carcinoma Progression After Insufficient Radiofrequency Ablation, and Attenuates Cell Sensitivity to Sorafenib Therapy

Frontiers in Oncology
Jian KongLemin Zheng

Abstract

Epithelial-mesenchymal transition (EMT) and angiogenesis is involved in tumor progression after radiofrequency ablation (RFA). ATPase inhibitory factor 1 (IF1) is a bad predictor of prognosis. Sorafenib inhibited EMT of hepatocellular carcinoma (HCC) after RFA. Whether IF1 promotes the EMT and angiogenesis of HCC and attenuates the effect of sorafenib after insufficient RFA is investigated. In this study, higher expression of IF1 was found in residual tumor after insufficient RFA. Hep3B or Huh7 cells after insufficient RFA were designated as Hep3B-H or Huh7-H cells in vitro. Hep3B-H or Huh7-H cells exhibited enhanced capacities of colony formation, migration, and increased expression of EMT associated markers and IF1 compared with Hep3B or Huh7 cells. IF1 knockdown in Hep3B-H or Huh7-H cells decreased the colony formation and migratory capacity, and IF1 overexpression in Hep3B or Huh7 cells increased these capacities. IF1 in HCC cells directly and indirectly affected angiogenesis of TAECs after insufficient RFA. IF1 promoted HCC cells growth and metastasis after insufficient RFA. IF1 increased HCC cells resistance after insufficient RFA to sorafenib. Higher IF1 expression indicated poor disease survival in HCC patients after so...Continue Reading

References

Jul 30, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yu-Quan XiongZhao-You Tang
Jun 5, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Shuhei YoshidaDetlef Schuppan
Jul 22, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ruipeng SongLianxin Liu
Mar 18, 2015·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Tao YinDiansheng Cui
Apr 24, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jessica LoTerence Kin Wah Lee
Feb 16, 2016·Biochimica Et Biophysica Acta·Javier García-Bermúdez, José M Cuezva
Mar 19, 2016·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Tetsuya IkemotoShinichiro Yamada
Feb 9, 2017·Cellular and Molecular Life Sciences : CMLS·Pau B Esparza-MoltóJosé M Cuezva
Feb 9, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Benjamin CadierUNKNOWN ANRS CO12 CirVir and CHANGH groups
Apr 12, 2017·Nature Reviews. Clinical Oncology·Tsukasa Shibue, Robert A Weinberg
Apr 27, 2017·Frontiers in Oncology·Lucía García-LedoJosé M Cuezva
Jul 19, 2017·Trends in Cancer·Gabriela Jiménez-Valerio, Oriol Casanovas
Nov 4, 2017·Biochimica Et Biophysica Acta. Bioenergetics·G SgarbiA Baracca
Jan 4, 2018·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Jiangzheng ZengRongcheng Luo
Jan 9, 2018·Lancet·Alejandro FornerJordi Bruix
Mar 23, 2018·Frontiers in Oncology·Pau B Esparza-Moltó, José M Cuezva
Oct 3, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael A MorseRichard S Finn
Oct 31, 2018·International Journal of Cancer. Journal International Du Cancer·Yun XiaGang Wu
Nov 2, 2019·Nature Reviews. Cancer·Elizabeth D WilliamsErik W Thompson

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection
protein assay
Assay
confocal microscopy
Xenograft
transfection

Software Mentioned

ImageJ
GraphPad Prism

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.